Krajina: Spojené štáty
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
IMIDACLOPRID (UNII: 3BN7M937V8) (IMIDACLOPRID - UNII:3BN7M937V8), MOXIDECTIN (UNII: NGU5H31YO9) (MOXIDECTIN - UNII:NGU5H31YO9)
Bayer HealthCare LLC Animal Health Division
IMIDACLOPRID
IMIDACLOPRID 100 mg in 1 mL
TOPICAL
PRESCRIPTION
Advantage Multi for Dogs is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and the treatment of Dirofilaria immitis circulating microfilariae in heartworm-positive dogs. Advantage Multi for Dogs kills adult fleas and is indicated for the treatment of flea infestations (Ctenocephalides felis ). Advantage Multi for Dogs is indicated for the treatment and control of sarcoptic mange caused by Sarcoptes scabiei var. canis. Advantage Multi for Dogs is also indicated for the treatment and control of the following intestinal parasites: Intestinal Parasite Intestinal Stage Adult Immature Adult Fourth Stage Larvae Hookworm Species Ancylostoma caninum X X X Uncinaria stenocephala X X X Roundworm Species Toxocara canis X X Toxascaris leonina X Whipworm Trichuris vulpis X Do not administer this product orally. (See WARNINGS.) Do not use this product (containing 2.5% moxidectin) on cats.
Applications Per Package: 6 x 0.4 mL tubes 6 x 1.0 mL tubes 6 x 2.5 mL tubes 6 x 4.0 mL tubes 6 x 5.0 mL tubes
New Animal Drug Application
ADVANTAGE MULTI FOR DOGS- IMIDACLOPRID MOXIDECTIN SOLUTION BAYER HEALTHCARE LLC ANIMAL HEALTH DIVISION ---------- ADVANTAGE MULTI FOR DOGS (IMIDACLOPRID + MOXIDECTIN) TOPICAL SOLUTION ONCE-A-MONTH TOPICAL SOLUTION FOR THE PREVENTION OF HEARTWORM DISEASE, THE TREATMENT OF CIRCULATING MICROFILARIAE, KILLS ADULT FLEAS, IS INDICATED FOR THE TREATMENT OF FLEA INFESTATIONS, THE TREATMENT AND CONTROL OF SARCOPTIC MANGE, AS WELL AS THE TREATMENT AND CONTROL OF INTESTINAL PARASITE INFECTIONS IN DOGS AND PUPPIES THAT ARE AT LEAST 7 WEEKS OF AGE AND THAT WEIGH AT LEAST 3 LBS . WARNING • • • (SEE CONTRAINDICATIONS, WARNINGS, HUMAN WARNINGS, AND ADVERSE REACTIONS, FOR MORE INFORMATION) CAUTION: Federal (U.S.A.) Law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION: _Advantage Multi_® _for Dogs _(10 % imidacloprid + 2.5 % moxidectin) is a colorless to yellow ready-to- use solution packaged in single dose applicator tubes for topical treatment of dogs. The formulation and dosage schedule are designed to provide a minimum of 4.5 mg/lb (10 mg/kg) imidacloprid and 1.1 mg/lb (2.5 mg/kg) moxidectin based on body weight. Imidacloprid is a chloronicotinyl nitroguanidine insecticide. The chemical name for imidacloprid is 1- [(6-Chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinimine. Moxidectin is a semisynthetic macrocyclic lactone endectocide derived from the actinomycete _Streptomycetes cyaneogriseus_ _noncyanogenus_. The chemical name for moxidectin is [6R, 23E, 25S(E)]-5-O- Demethyl-28-deoxy-25- (1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino) milbemycin B. INDICATIONS: _Advantage Multi for Dogs _is indicated for the prevention of heartworm disease caused by _Dirofilaria_ _immitis _and the treatment of _Dirofilaria immitis _circulating microfilariae in heartworm-positive dogs. _Advantage Multi for Dogs _kills adult fleas and is indicated for the treatment of flea infestations (_Ctenocephalides felis_). _Advantage Multi for Dogs _is indicated for the treatment and control of sarcoptic Prečítajte si celý dokument